PMID- 27523033 OWN - NLM STAT- MEDLINE DCOM- 20171116 LR - 20181113 IS - 1872-678X (Electronic) IS - 0165-0270 (Print) IS - 0165-0270 (Linking) VI - 273 DP - 2016 Nov 1 TI - Liposome-entrapped GABA modulates the expression of nNOS in NG108-15 cells. PG - 55-63 LID - S0165-0270(16)30183-2 [pii] LID - 10.1016/j.jneumeth.2016.08.004 [doi] AB - BACKGROUND: Liposomes are concentric lipid vesicles that allow a sustained release of entrapped substances. GABA (gamma-aminobutyric acid) is the most prevalent inhibitory neurotransmitter in the central nervous system. NEW METHOD: Using GABA-containing liposomes (GL) prepared by the freeze-thawing method, we determined the effect of sustained release of GABA on expression of neuronal nitric oxide synthase (nNOS) and GABA(A) receptor (GABA(A)R) in an in vitro neuronal model. RESULTS: Neuronal cell line NG108-15 treated with different doses of GL during 24h showed an increase in expression of GABA(A)R (54 and 50% with 10 and 20ng doses, respectively) and nNOS (138, 157 and 165% with 20, 50 and 100ng doses, respectively) compared with cells treated with empty liposomes (EL). Additionally, cells treated with 50ng of GL showed an increase in GABA(A)R (23%) after 1h followed by an increase in nNOS (55, 46 and 55%) at 8, 12 and 24h time points, respectively. Immunofluorescence experiments confirmed an increase in nNOS (134%) and basal intracellular levels of nitric oxide (84%) after GL treatment. Further, treatment of cells with GL showed a decrease in expression of a protein inhibitor of nNOS (PIN) (26, 66 and 57% with 20, 50 and 100ng doses respectively) compared with control. COMPARISON WITH EXISTING METHODS: This is first demonstration for the development of GL that allows sustained slow release of this neurotransmitter. CONCLUSION: These results suggest that a slow release of GABA can change the expression of nNOS possibly via alteration in PIN levels in neuronal cells. CI - Copyright (c) 2016 Elsevier B.V. All rights reserved. FAU - Vaz, Gisele C AU - Vaz GC AD - Department of Physiology & Biophysics, Federal University of Minas Gerais, Belo Horizonte, Brazil. FAU - Sharma, Neeru M AU - Sharma NM AD - Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5850, United States. FAU - Zheng, Hong AU - Zheng H AD - Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5850, United States. FAU - Zimmerman, Matthew C AU - Zimmerman MC AD - Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5850, United States. FAU - Santos, Robson S AU - Santos RS AD - Department of Physiology & Biophysics, Federal University of Minas Gerais, Belo Horizonte, Brazil. FAU - Frezard, Frederic AU - Frezard F AD - Department of Physiology & Biophysics, Federal University of Minas Gerais, Belo Horizonte, Brazil. FAU - Fontes, Marco A P AU - Fontes MAP AD - Department of Physiology & Biophysics, Federal University of Minas Gerais, Belo Horizonte, Brazil. FAU - Patel, Kaushik P AU - Patel KP AD - Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5850, United States. Electronic address: kpatel@unmc.edu. LA - eng GR - P01 HL062222/HL/NHLBI NIH HHS/United States GR - P30 GM106397/GM/NIGMS NIH HHS/United States GR - R01 DK082956/DK/NIDDK NIH HHS/United States GR - R01 HL124104/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20160811 PL - Netherlands TA - J Neurosci Methods JT - Journal of neuroscience methods JID - 7905558 RN - 0 (Liposomes) RN - 0 (Nitrites) RN - 0 (RNA, Small Interfering) RN - 0 (Receptors, GABA-A) RN - 3KX376GY7L (Glutamic Acid) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type I) RN - EC 2.3.1.48 (CREB-Binding Protein) RN - EC 3.6.1.- (Dynll1 protein, rat) RN - EC 3.6.4.2 (Cytoplasmic Dyneins) SB - IM MH - Animals MH - CREB-Binding Protein/metabolism MH - Cell Line, Tumor MH - Cytoplasmic Dyneins/metabolism MH - Dose-Response Relationship, Drug MH - Drug Delivery Systems MH - Gene Expression Regulation, Neoplastic/*drug effects MH - Glutamic Acid/pharmacology MH - Liposomes/*administration & dosage/pharmacology MH - Mice MH - Neuroblastoma/pathology MH - Nitric Oxide Synthase Type I/*metabolism MH - Nitrites/metabolism MH - RNA, Small Interfering/pharmacology MH - Rats MH - Receptors, GABA-A/metabolism MH - Time Factors MH - gamma-Aminobutyric Acid/*administration & dosage/pharmacology PMC - PMC5075514 MID - NIHMS811450 OTO - NOTNLM OT - GABA OT - Liposome OT - NG108-15 OT - PIN OT - nNOS COIS- None. EDAT- 2016/10/25 06:00 MHDA- 2017/11/29 06:00 PMCR- 2017/11/01 CRDT- 2016/08/16 06:00 PHST- 2016/04/12 00:00 [received] PHST- 2016/07/25 00:00 [revised] PHST- 2016/08/05 00:00 [accepted] PHST- 2016/10/25 06:00 [pubmed] PHST- 2017/11/29 06:00 [medline] PHST- 2016/08/16 06:00 [entrez] PHST- 2017/11/01 00:00 [pmc-release] AID - S0165-0270(16)30183-2 [pii] AID - 10.1016/j.jneumeth.2016.08.004 [doi] PST - ppublish SO - J Neurosci Methods. 2016 Nov 1;273:55-63. doi: 10.1016/j.jneumeth.2016.08.004. Epub 2016 Aug 11.